Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)

enthalten in: Cancers | 2019

von Schokker, S. | van der Woude, S. | van Kleef, J. | +13

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)

in: Cancers | 2019

von Sandor Schokker | Stephanie O. van der Woude | Jessy Joy van Kleef | +13